Inspire IVF Public Company Limited
0.70
THB
-0.01
(-1.41%)
ISIN
THC574010003
Return %
Stock
S&P 500
1Y
-25.53
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Kasinee Kuldiloke
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Bangkok Thailand
- IPO Date
- Dec 11, 2024
- Website
- inspireivf.com
- Similar Companies
- Business
- Inspire IVF Public Company Limited is a Thailand-based healthcare provider specializing in assisted reproductive technology and comprehensive fertility treatment solutions for domestic and international patients. The company operates specialized fertility centers offering end-to-end reproductive medical services across several core categories: assisted reproductive technologies, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and blastocyst culture; advanced genetic testing and embryo screening, featuring pre-implantation genetic testing for aneuploidy (PGT-A), pre-implantation genetic testing for monogenic disorders (PGT-M), pre-implantation genetic testing for chromosomal structural rearrangements (PGT-SR), and next-generation sequencing (NGS); fertility preservation solutions, comprising oocyte cryopreservation, sperm cryopreservation, and embryo vitrification and long-term storage; specialized diagnostic and andrology laboratory services, including comprehensive semen analysis, sperm DNA fragmentation testing, endometrial receptivity analysis, and diagnostic hysteroscopy; and supportive healthcare services, encompassing gynecological consultations, hormone profiling, prenatal screening, and fertility-focused wellness support. Founded in 2017 and headquartered in Bangkok, Thailand, the company serves individuals and couples experiencing infertility, elective fertility preservation clients, and medical tourists, primarily from Thailand, Greater China, and neighboring Southeast Asian countries. In recent developments, Inspire IVF Public Company Limited completed its initial public offering and listing on the Market for Alternative Investment of the Stock Exchange of Thailand under the ticker symbol IVF to finance the expansion of its clinical facilities and technological infrastructure. The company has enhanced its embryology laboratory operations through the adoption of time-lapse embryo incubation systems and artificial intelligence-assisted embryo grading technologies, while expanding its cross-border patient referral network through strategic agency partnerships across East and Southeast Asia.